Consolidation in the hospital and healthcare delivery sectors has better positioned larger hospital systems to negotiate lower prices for medical device products and technologies. This trend has introduced new levels of pricing pressure on manufacturers and is driving interest in alternative pricing models — including value-based agreements — across the sector.
Takeaways from roundtable discussion on Medical Affairs challenges at MAPS 2023 Global Annual Meeting
In spring 2023, CRA’s Life Sciences Practice held a roundtable discussion with Medical Affairs leaders to better understand obstacles prohibiting their teams...